Kelleher Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.41M | Buy |
17,508
+5,868
| +50% | +$1.26M | 0.63% | 38 |
|
|
2026
Q1 | $2.33M | Sell |
11,640
-263
| -2% | -$58.3K | 0.59% | 38 |
|
|
2025
Q4 | $2.72M | Buy |
11,903
+5,315
| +81% | +$1.21M | 0.62% | 33 |
|
|
2025
Q3 | $1.53M | Sell |
6,588
-4,931
| -43% | -$1M | 0.38% | 47 |
|
|
2025
Q2 | $2.14M | Buy |
11,519
+1,558
| +16% | +$290K | 0.74% | 24 |
|
|
2025
Q1 | $2.09M | Sell |
9,961
-1,276
| -11% | -$248K | 0.83% | 22 |
|
|
2024
Q4 | $2M | Sell |
11,237
-24
| -0.2% | -$4.41K | 0.75% | 21 |
|
|
2024
Q3 | $2.22M | Buy |
11,261
+186
| +2% | +$34.7K | 0.85% | 20 |
|
|
2024
Q2 | $1.9M | Sell |
11,075
-827
| -7% | -$137K | 0.78% | 20 |
|
|
2024
Q1 | $2.17M | Buy |
11,902
+1,593
| +15% | +$275K | 0.9% | 19 |
|
|
2023
Q4 | $1.6M | Sell |
10,309
-292
| -3% | -$42.6K | 0.75% | 20 |
|
|
2023
Q3 | $1.58M | Sell |
10,601
-679
| -6% | -$99.7K | 0.81% | 20 |
|
|
2023
Q2 | $1.52M | Buy |
11,280
+1,074
| +11% | +$157K | 0.88% | 20 |
|
|
2023
Q1 | $1.63M | Sell |
10,206
-826
| -7% | -$126K | 1.07% | 17 |
|
|
2022
Q4 | $1.78M | Sell |
11,032
-3,732
| -25% | -$572K | 1.34% | 12 |
|
|
2022
Q3 | $1.18M | Buy |
14,764
+751
| +5% | +$108K | 0.85% | 24 |
|
|
2022
Q2 | $21.5M | Buy |
14,013
+56
| +0.4% | +$8.56K | 9.66% | 3 |
|
|
2022
Q1 | $2.26M | Buy |
13,957
+36
| +0.3% | +$5.23K | 1.25% | 15 |
|
|
2021
Q4 | $1.8M | Sell |
13,921
-4,428
| -24% | -$523K | 0.96% | 20 |
|
|
2021
Q3 | $1.98M | Buy |
18,349
+4,965
| +37% | +$567K | 0.87% | 23 |
|
|
2021
Q2 | $1.51M | Buy |
13,384
+257
| +2% | +$28.9K | 0.85% | 23 |
|
|
2021
Q1 | $1.42M | Buy |
13,127
+111
| +0.9% | +$11.9K | 0.91% | 21 |
|
|
2020
Q4 | $1.39M | Buy |
13,016
+290
| +2% | +$27.9K | 1.05% | 17 |
|
|
2020
Q3 | $1.11M | Sell |
12,726
-67
| -0.5% | -$6.31K | 0.92% | 18 |
|
|
2020
Q2 | $1.25M | Buy |
12,793
+4,416
| +53% | +$389K | 1.21% | 16 |
|
|
2020
Q1 | $638K | Buy |
8,377
+105
| +1% | +$8.94K | 0.76% | 29 |
|
|
2019
Q4 | $732K | Buy |
8,272
+2,958
| +56% | +$246K | 0.74% | 32 |
|
|
2019
Q3 | $402K | Hold |
5,314
| – | – | 0.49% | 50 |
|
|
2019
Q2 | $386K | Buy |
+5,314
| New | +$418K | 0.48% | 54 |
|
|
2018
Q4 | $489K | Hold |
5,314
| – | – | 0.79% | 34 |
|
|
2018
Q3 | $502K | Sell |
5,314
-4,468
| -46% | -$424K | 0.65% | 42 |
|
|
2018
Q2 | $764K | Buy |
9,782
+4,468
| +84% | +$436K | 1.09% | 20 |
|
|
2018
Q1 | $502K | Buy |
5,314
+1,600
| +43% | +$176K | 0.68% | 41 |
|
|
2017
Q4 | $359K | Buy |
+3,714
| New | +$350K | 0.57% | 53 |
|
|
2017
Q1 | – | Sell |
-72,900
| Closed | -$4.56M | – | 86 |
|
|
2016
Q4 | $4.56M | Sell |
72,900
-400
| -0.5% | -$24.4K | 2.54% | 7 |
|
|
2016
Q3 | $4.62M | Sell |
73,300
-350
| -0.5% | -$22.7K | 2.62% | 8 |
|
|
2016
Q2 | $4.56M | Sell |
73,650
-450
| -0.6% | -$27.4K | 2.76% | 8 |
|
|
2016
Q1 | $4.23M | Buy |
74,100
+50
| +0.1% | +$2.79K | 2.33% | 8 |
|
|
2015
Q4 | $4.39M | Buy |
74,050
+8,466
| +13% | +$488K | 2.97% | 7 |
|
|
2015
Q3 | $3.57M | Sell |
65,584
-1,300
| -2% | -$84.6K | 2.37% | 10 |
|
|
2015
Q2 | $4.49M | Sell |
66,884
-300
| -0.4% | -$19.6K | 2.56% | 7 |
|
|
2015
Q1 | $3.93M | Buy |
67,184
+34
| +0.1% | +$2.05K | 2.17% | 13 |
|
|
2014
Q4 | $4.39M | Sell |
67,150
-150
| -0.2% | -$9.46K | 2.36% | 11 |
|
|
2014
Q3 | $4.25M | Buy |
67,300
+500
| +0.7% | +$27.8K | 2.3% | 11 |
|
|
2014
Q2 | $3.77M | Buy |
66,800
+450
| +0.7% | +$23.6K | 1.97% | 13 |
|
|
2014
Q1 | $3.41M | Buy |
66,350
+450
| +0.7% | +$22.7K | 1.85% | 15 |
|
|
2013
Q4 | $3.48M | Buy |
65,900
+5,000
| +8% | +$246K | 1.8% | 14 |
|
|
2013
Q3 | $2.72M | Sell |
60,900
-300
| -0.5% | -$13.3K | 1.55% | 18 |
|
|
2013
Q2 | $2.41M | Buy |
+61,200
| New | +$2.68M | 1.47% | 23 |
|
Other funds holding ABBV
Kelleher Financial Advisors's ABBV Position: Q2 2026 in Review
Kelleher Financial Advisors increased its AbbVie (ABBV) stake by 50% in Q2 2026, buying an estimated $1.26M and bringing the position to 17,508 shares worth $4.41M. The position accounts for 0.63% of the portfolio, ranked #38.
Kelleher Financial Advisors first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $21.5M in Q2 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Kelleher Financial Advisors held 17,508 shares of AbbVie worth $4.41M as of Q2 2026.
- Kelleher Financial Advisors bought 5,868 AbbVie shares in Q2 2026, an estimated $1.26M.
- AbbVie made up 0.63% of Kelleher Financial Advisors's portfolio in Q2 2026, its #38 holding.
- Kelleher Financial Advisors first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- Kelleher Financial Advisors's AbbVie position peaked at $21.5M in Q2 2022.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.